Sharemaestro Newsreel

UnitedHealth Group stock steadies as Medicare and Optum growth offset higher medical costs

UnitedHealth Group's stock remains steady as strong revenue growth from its Medicare Advantage and Optum segments helps counterbalance increased medical costs. The company reported consolidated revenue of approximately $99 billion in Q1 2024, an 8% increase year-over-year, and reiterated its full-year guidance for continued …

ALHC Investors Have Opportunity to Join Alignment Healthcare, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) on behalf of investors following allegations of accounting irregularities. A whistleblower lawsuit filed on July 8, 2026, claims the company misclassified operating expenses in 2024 and 2025 to inflate its EBITDA, leading to …

President of Elevance Health Gail Boudreaux Buys 1.9% More Shares

Elevance Health's President, Gail Boudreaux, recently purchased US$1.0m worth of company stock at US$368 per share, increasing her holding by 1.9%. This substantial insider buy suggests confidence in the company's future, despite the current share price being slightly higher than the average insider purchase …

Elevance Health, Inc. (ELV) Q4 2025 Earnings Report - Results, Call & Slides

Elevance Health, Inc. (ELV) reported its Q4 2025 earnings, beating the consensus EPS but missing revenue expectations. The company recorded an actual EPS of $57.88 against a consensus of $53.82, while its actual revenue of $864.71 billion fell short of the $866.40 billion expected. …

Weiss Asset Management LP Buys 12,685 Shares of Humana Inc. $HUM

Weiss Asset Management LP increased its stake in Humana Inc. by 45% in the first quarter, purchasing an additional 12,685 shares, bringing their total holdings to 40,891 shares valued at approximately $7.09 million. The increase follows Humana's strong quarterly results, where it exceeded EPS …

Centene stock holds steady as Medicaid membership and revenue guidance frame investor focus

Centene Corp. (ISIN US15133V1035) stock remains stable as investors focus on its strong Medicaid and government health contracts. The company reported roughly $156 billion in revenue for fiscal year 2024 and provided guidance for approximately $160 billion in 2025, highlighting its reliance on membership …

Healthcare of Ontario Pension Plan Trust Fund Raises Stock Position in Humana Inc. $HUM

Healthcare of Ontario Pension Plan Trust Fund significantly increased its stake in Humana Inc. by 3,350.6% in the first quarter, now owning 336,572 shares valued at $58,358,000. Other institutional investors like Vanguard Group Inc., Capital International Investors, Pzena Investment Management LLC, State Street Corp, …

CNC|Centene Corp|Price:63.410|Chg%:-0.330

This article provides a detailed financial overview of Centene Corp (CNC), including its stock performance, key financial indicators like EPS, revenue, net profit, and margins across quarterly and annual periods. It highlights financial statements such as the income statement, balance sheet, and cash flow …

Allspring Global Investments Holdings LLC Trims Stake in Healthcare Services Group, Inc. $HCSG

Allspring Global Investments Holdings LLC significantly reduced its stake in Healthcare Services Group, Inc. (NASDAQ:HCSG) by 59.1% in the first quarter, now owning 143,321 shares valued at $2.66 million. Despite this trimming by Allspring, other institutional investors like Jane Street Group LLC and Invesco …

Alignment Healthcare (ALHC) Stock Looks Below Fair Value After Legal Questions

Alignment Healthcare (ALHC) stock has seen a significant 237.9% return over three years but is currently screening as undervalued in Simply Wall St's checks. The company faces fresh legal and regulatory questions, including whistleblower allegations and a lawsuit concerning Medicare Advantage star ratings, which …

Molina Healthcare, Inc. Revenue Breakdown – SWB:MHG

Molina Healthcare, Inc. (SWB:MHG) generated 38.68 billion EUR in revenue last year, with its Medicaid segment being the top performer at 27.45 billion EUR. The United States was the primary geographic contributor, accounting for the entire 38.68 billion EUR. The company's revenue slightly decreased …

Alignment Healthcare (ALHC) Stock Looks Reasonable On Its 238% Three Year Run

Alignment Healthcare (ALHC) has seen a significant 238% return over the past three years, though recent short-term weakness and ongoing legal scrutiny are factors. Despite its strong performance, the stock currently appears undervalued based on its Price/Sales (P/S) ratio compared to the healthcare industry …

UnitedHealth Group stock trades steadily as earnings and Optum growth shape outlook

UnitedHealth Group's stock performance is influenced by its Medicare exposure and Optum's growth, with recent earnings showing robust revenue growth driven by both UnitedHealthcare and Optum segments. Optum, particularly Optum Health and Optum Rx, is highlighted for its higher-margin health services and faster growth, …

Progyny Inc (PGNY) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Progyny Inc (PGNY) stock, focusing on its dividend and stock split history. It notes that the company has not distributed any dividends over the past five years. Key financial data like market cap and P/E ratio are also …

Clover Health Investments Corp. Class A Revenue Breakdown – MUN:7QD

Clover Health Investments Corp. (MUN:7QD) generated €1.64 billion in revenue last year, primarily from its Insurance segment. All of this revenue, €1.64 billion, originated from the United States, indicating the company's strong focus on the US market in the life and health insurance sector.

ETFs Investing in Alignment Healthcare, Inc. Stocks

This article lists various ETFs that include Alignment Healthcare, Inc. (ALHC) stocks in their portfolios. It provides a detailed table with each ETF's market value, weight of ALHC stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, relative volume, …

CVS Health Corp (CVS) Valuation: PE, PB & Fair Value Analysis

This article provides an analysis of CVS Health Corp's (CVS) valuation, noting its current valuation score of 8.27 and its ranking within the Healthcare Providers & Services industry. It highlights the current P/E ratio, comparing it to recent highs and lows, while also mentioning …

UnitedHealth Group stock trades steadily as earnings and growth outlook frame investor focus

UnitedHealth Group's stock performance is being driven by strong recent earnings, growth in its Optum health services, and its significant presence in the US healthcare market. The company consistently reports high consolidated revenue, with year-on-year growth from both its UnitedHealthcare insurance segment and its …

Centene Corporation Revenue Breakdown – NYSE:CNC

AI-Powered Care Management And Dividend Hike Could Be A Game Changer For Cigna Group (CI)

Cigna Group recently announced a quarterly dividend of US$1.56 per share and expanded its AI-enabled care management programs to support more customers with complex conditions. The company anticipates US$200 million in medical cost savings over three years from this AI-driven predictive analytics initiative, reinforcing …

Elevance Health Inc (ELV) Financial Health: Profitability & Balance Sheet Analysis

The article provides a financial health analysis of Elevance Health Inc (ELV), indicating a current financial score of 4.84, which ranks 74 out of 75 in its industry, suggesting a weak financial status and low operating efficiency. Despite this, the company reported a year-over-year …

PGNY|Progyny Inc|Price:31.190|Chg%:+0.490

This article provides an in-depth analysis of Progyny Inc. (PGNY), highlighting its strong fundamentals, high growth potential, and relatively fair valuation. It notes that institutional ownership is high and analysts widely rate the stock as a "Buy" with an upward trend expected in the …

Centene stock remains anchored by Medicaid scale and earnings

Centene Corp. reported strong financial results for 2025, with $163.1 billion in premium and service revenues and adjusted diluted EPS of $7.11. The company's large membership base of 28.7 million, primarily driven by government-sponsored programs like Medicaid, anchors its financial performance. Centene's medical cost …

Molina Healthcare (MOH) Plans Big 2027 ACA Pullback After Profit Pressure

Elevance Health Stock (ELV) Opinions on Q2 Earnings and Medicaid Exits

UnitedHealth Group stock steadies as Q2 2026 results highlight growth and Medicare changes

UnitedHealth Group reported a 15% rise in Q2 2026 revenue to $110 billion, driven by growth in both its insurance and Optum health services segments, with adjusted EPS also increasing. The company's Q2 results reflect strong core profitability despite ongoing regulatory changes in Medicare …

CVS HEALTH CORP : UBS RAISES TARGET PRICE TO $122 FROM $115

UBS has increased its target price for CVS Health Corp (CVS.N) to $122 from $115. This news was reported by Reuters. The article highlights an analyst action related to CVS Health Corp's stock.

Earnings Preview: Cigna Group to Report Financial Results Pre-market on July 30

Cigna Group is scheduled to report its financial results pre-market on July 30. This earnings preview indicates investors should prepare for the release of their latest financial performance data.

CVS Health Corp (CVS) - Tradingkey Stock Score & Comprehensive Stock Analysis

This article provides a comprehensive stock analysis of CVS Health Corp (CVS) from TradingKey, highlighting its "Stock Score" which evaluates financial health, valuation, earnings forecast, price momentum, institutional confidence, and risk assessment. CVS shows stable fundamentals with significant growth potential, is considered fairly valued …

UNH|Unitedhealth Group Inc|Price:417.570|Chg%:-3.170

UnitedHealth Group Inc. (UNH) shows healthy fundamentals and significant growth potential, with its valuation considered fairly valued within the Healthcare Providers & Services industry. The stock price is currently trending sideways but is expected to trend upwards in the medium term, despite recent average …

Molina Healthcare Inc. stock underperforms Friday when compared to competitors

Molina Healthcare Inc. (MOH) stock fell 1.37% on Friday, closing at $197.55, despite a positive trading session for the broader market. This marks the fourth consecutive day of losses for the company, as the S&P 500 Index and Dow Jones Industrial Average both saw …

Clover Health Data Breach Lawsuit Investigation

Shamis & Gentile P.A. is investigating a data breach involving Clover Health Investments, Corp. dba Clover Health. The breach, which was detected on July 8, 2020, and disclosed to the SEC on July 4, 2026, exposed sensitive personally identifiable and protected health information. Individuals …

UnitedHealth Group Incorporated Revenue Breakdown – BCS:UNH

This article details the revenue breakdown for UnitedHealth Group Incorporated (UNH). Last year, the company generated $447.57 billion USD, with its UnitedHealthcare segment contributing the largest portion at $344.90 billion USD. The United States was the primary geographical contributor, accounting for $447.57 billion USD …

Humana Inc. Revenue Breakdown – NYSE:HUM

Humana Inc.'s revenue reached $129.66 billion USD last year, primarily driven by its Insurance segment which generated $124.56 billion USD. The majority of this revenue, $129.66 billion USD, originated from operations within the United States. This indicates a strong performance in its core insurance …

Humana Inc. stock underperforms Friday when compared to competitors

Humana Inc. (HUM) shares fell 1.31% to $389.32 on Friday, despite a positive trading session for the broader market, with both the S&P 500 Index and the Dow Jones Industrial Average seeing gains. This marks the third consecutive day of losses for the stock.

Can Humana Beat Q2 Earnings Estimates on Growing Premiums?

Humana (HUM) is expected to announce its Q2 2026 earnings on July 29, with analysts predicting a slight year-over-year decrease in EPS but significant revenue growth due to increasing premiums. The company has a positive Earnings ESP and a Zacks Rank #1, suggesting a …